AVITA Medical (RCEL) Competitors $12.59 -0.46 (-3.52%) (As of 10:32 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends RCEL vs. ESTA, BLFS, AORT, PLSE, BVS, CBLL, EYE, FNA, LQDA, and AVNSShould you be buying AVITA Medical stock or one of its competitors? The main competitors of AVITA Medical include Establishment Labs (ESTA), BioLife Solutions (BLFS), Artivion (AORT), Pulse Biosciences (PLSE), Bioventus (BVS), CeriBell (CBLL), National Vision (EYE), Paragon 28 (FNA), Liquidia (LQDA), and Avanos Medical (AVNS). These companies are all part of the "medical equipment" industry. AVITA Medical vs. Establishment Labs BioLife Solutions Artivion Pulse Biosciences Bioventus CeriBell National Vision Paragon 28 Liquidia Avanos Medical Establishment Labs (NASDAQ:ESTA) and AVITA Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment. Does the media favor ESTA or RCEL? In the previous week, Establishment Labs had 2 more articles in the media than AVITA Medical. MarketBeat recorded 2 mentions for Establishment Labs and 0 mentions for AVITA Medical. Establishment Labs' average media sentiment score of 0.56 beat AVITA Medical's score of 0.00 indicating that Establishment Labs is being referred to more favorably in the media. Company Overall Sentiment Establishment Labs Positive AVITA Medical Neutral Does the MarketBeat Community favor ESTA or RCEL? Establishment Labs received 42 more outperform votes than AVITA Medical when rated by MarketBeat users. However, 67.89% of users gave AVITA Medical an outperform vote while only 61.70% of users gave Establishment Labs an outperform vote. CompanyUnderperformOutperformEstablishment LabsOutperform Votes11661.70% Underperform Votes7238.30% AVITA MedicalOutperform Votes7467.89% Underperform Votes3532.11% Do analysts prefer ESTA or RCEL? Establishment Labs presently has a consensus target price of $60.60, suggesting a potential upside of 42.19%. AVITA Medical has a consensus target price of $16.50, suggesting a potential upside of 31.06%. Given Establishment Labs' stronger consensus rating and higher possible upside, equities research analysts clearly believe Establishment Labs is more favorable than AVITA Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Establishment Labs 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80AVITA Medical 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 Do insiders & institutionals believe in ESTA or RCEL? 72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 27.7% of AVITA Medical shares are held by institutional investors. 11.4% of Establishment Labs shares are held by insiders. Comparatively, 1.8% of AVITA Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more risk & volatility, ESTA or RCEL? Establishment Labs has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Comparatively, AVITA Medical has a beta of 1.54, suggesting that its share price is 54% more volatile than the S&P 500. Is ESTA or RCEL more profitable? Establishment Labs has a net margin of -46.13% compared to AVITA Medical's net margin of -95.47%. Establishment Labs' return on equity of -184.55% beat AVITA Medical's return on equity.Company Net Margins Return on Equity Return on Assets Establishment Labs-46.13% -184.55% -24.81% AVITA Medical -95.47%-194.69%-60.67% Which has better earnings and valuation, ESTA or RCEL? AVITA Medical has lower revenue, but higher earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than AVITA Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEstablishment Labs$165.15M7.23-$78.50M-$2.58-16.52AVITA Medical$50.14M6.58-$35.38M-$2.23-5.65 SummaryEstablishment Labs beats AVITA Medical on 13 of the 18 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get AVITA Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RCEL vs. The Competition Export to ExcelMetricAVITA MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$330.11M$4.43B$5.07B$8.80BDividend YieldN/A36.79%4.99%4.07%P/E Ratio-5.6513.5789.5613.60Price / Sales6.5844.221,224.8087.40Price / CashN/A52.2739.4536.27Price / Book26.795.776.976.33Net Income-$35.38M$13.76M$119.04M$225.93M7 Day Performance0.08%-0.99%-1.78%-0.96%1 Month Performance19.68%0.71%-3.59%1.06%1 Year Performance23.80%51.46%31.64%26.59% AVITA Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RCELAVITA Medical1.4051 of 5 stars$12.59-3.5%$16.50+31.1%+4.1%$330.11M$50.14M-5.65130ESTAEstablishment Labs2.1311 of 5 stars$42.62+1.9%$60.60+42.2%+90.0%$1.19B$165.15M0.00960BLFSBioLife Solutions1.5082 of 5 stars$25.32+1.2%$27.50+8.6%+86.5%$1.17B$143.27M0.00409Analyst ForecastInsider TradeAnalyst RevisionAORTArtivion1.9824 of 5 stars$27.23+0.2%$31.00+13.8%+92.4%$1.14B$354M-1,358.001,500Positive NewsPLSEPulse Biosciences1.5374 of 5 stars$16.13-0.1%N/A+157.8%$992.32M$700,000.000.00140Positive NewsBVSBioventus2.7337 of 5 stars$11.35-0.5%$13.00+14.5%+195.6%$921.05M$512.34M29.721,200Positive NewsCBLLCeriBellN/A$25.27+0.8%$31.20+23.5%N/A$905.17MN/A0.00N/AQuiet Period ExpirationAnalyst RevisionGap UpEYENational Vision3.0672 of 5 stars$11.28-0.5%$14.00+24.1%-42.1%$888.30M$2.13B-56.7013,998Positive NewsFNAParagon 282.1583 of 5 stars$10.21-1.4%$15.60+52.8%-0.3%$854.78M$216.39M-13.99343,000Analyst RevisionLQDALiquidia3.7431 of 5 stars$10.01-1.1%$24.00+139.8%+55.7%$847.25M$17.49M-6.2150Analyst RevisionAVNSAvanos Medical3.9871 of 5 stars$18.12+1.4%N/A-16.6%$832.80M$673.30M52.563,771Positive News Related Companies and Tools Related Companies Establishment Labs Alternatives BioLife Solutions Alternatives Artivion Alternatives Pulse Biosciences Alternatives Bioventus Alternatives CeriBell Alternatives National Vision Alternatives Paragon 28 Alternatives Liquidia Alternatives Avanos Medical Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RCEL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVITA Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
